Bleeding: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:


== Bleeding definition for the Cardiovascular Trials==
== Bleeding definition for the Cardiovascular Trials==
===Overview===
[[Background]], [[TIMI]], [[GUSTO]], [[CURE]], [[ACUITY HORIZONS]], [[CURRENT OASIS]], [[STEEPLE]], [[PLATO]], [[GRACE]], [[ISAR-REACT3]], [[ESSENCE]], the [[Bleeding Academic Research Consortium]] ([[BARC]])
The incidence of [[bleeding]] complications varies from 1% to 10% during treatment of [[acute coronary syndromes]] ([[ACS]]) and [[PCI]] ([[Percutaneous coronary intervention]]). This is in part due to use of combination of multiple drugs like [[aspirin]], [[heparin]], [[warfarin]], [[platelet P2Y12 inhibitors]], [[glycoprotein IIb/IIIa inhibitors]], [[direct thrombin inhibitor]] and also the invasive procedures (percutaneous coronary intervention, [[Coronary artery bypass graft]]) during this period. Also, the bleeding complications have been found to be associated with increase in incidence of short and long term adverse outcomes like death, non-fatal [[MI]] (myocardial infarction), [[stroke]] and [[stent thrombosis]]. The exact mechanism underlying this is not clearly defined but may be due to the cessation of evidence based therapies (like [[antiplatelet]], [[Beta blockers]], [[statin]]), effect of[[ blood transfusion]], co morbidities and [[anemia]] that are seen more in patients with bleeding complications. Therefore, bleeding presents as an important safety endpoint in many of the cardiovascular trials.  
The incidence of [[bleeding]] complications varies from 1% to 10% during treatment of [[acute coronary syndromes]] ([[ACS]]) and [[PCI]] ([[Percutaneous coronary intervention]]). This is in part due to use of combination of multiple drugs like [[aspirin]], [[heparin]], [[warfarin]], [[platelet P2Y12 inhibitors]], [[glycoprotein IIb/IIIa inhibitors]], [[direct thrombin inhibitor]] and also the invasive procedures (percutaneous coronary intervention, [[Coronary artery bypass graft]]) during this period. Also, the bleeding complications have been found to be associated with increase in incidence of short and long term adverse outcomes like death, non-fatal [[MI]] (myocardial infarction), [[stroke]] and [[stent thrombosis]]. The exact mechanism underlying this is not clearly defined but may be due to the cessation of evidence based therapies (like [[antiplatelet]], [[Beta blockers]], [[statin]]), effect of[[ blood transfusion]], co morbidities and [[anemia]] that are seen more in patients with bleeding complications. Therefore, bleeding presents as an important safety endpoint in many of the cardiovascular trials.  
However, there is a lack of uniformity in the definitions of bleeding that could be used in the cardiovascular trials that in turn make it difficult to conduct and compare the results of different trials. Several bleeding definitions have been used in different clinical trials – [[TIMI]], [[GUSTO]], [[CURE]], [[ACUITY HORIZONS]], [[CURRENT OASIS]], [[STEEPLE]], [[PLATO]], [[GRACE]], [[ISAR-REACT3]], [[ESSENCE]], [[Amlani. et.al]]. .To decrease the heterogeneity and to adopt standardized bleeding end-point definitions for patients receiving antithrombotic therapy, the [[Bleeding Academic Research Consortium]] ([[BARC]]) was convened comprising representatives from different fields of medicine. These standardized definitions will help researchers determine the relative safety of different antithrombotic therapies. These definitions are recommended for both clinical trials and registries<ref name="pmid21670242">{{cite journal| author=Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J et al.| title=Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. | journal=Circulation | year= 2011 | volume= 123 | issue= 23 | pages= 2736-47 | pmid=21670242 | doi=10.1161/CIRCULATIONAHA.110.009449 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21670242  }} </ref>.
However, there is a lack of uniformity in the definitions of bleeding that could be used in the cardiovascular trials that in turn make it difficult to conduct and compare the results of different trials. Several bleeding definitions have been used in different clinical trials – [[TIMI]], [[GUSTO]], [[CURE]], [[ACUITY HORIZONS]], [[CURRENT OASIS]], [[STEEPLE]], [[PLATO]], [[GRACE]], [[ISAR-REACT3]], [[ESSENCE]], [[Amlani. et.al]]. .To decrease the heterogeneity and to adopt standardized bleeding end-point definitions for patients receiving antithrombotic therapy, the [[Bleeding Academic Research Consortium]] ([[BARC]]) was convened comprising representatives from different fields of medicine. These standardized definitions will help researchers determine the relative safety of different antithrombotic therapies. These definitions are recommended for both clinical trials and registries<ref name="pmid21670242">{{cite journal| author=Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J et al.| title=Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. | journal=Circulation | year= 2011 | volume= 123 | issue= 23 | pages= 2736-47 | pmid=21670242 | doi=10.1161/CIRCULATIONAHA.110.009449 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21670242  }} </ref>.
Line 16: Line 16:


==[[First aid]] ==
==[[First aid]] ==
All people who have been injured should receive a thorough assessment. It should be divided into a primary and secondary survey and performed in a stepwise fashion, following the "[[ABC (medical)|ABC]]s". Notification of [[Emergency medical services|EMS]] or other rescue agencies should be performed in a timely manner and as the situation requires.
The '''primary survey''' examines and verifies that the patient's '''A'''irway is intact, that s/he is '''B'''reathing and that '''C'''irculation is working. A similar scheme and mnemonic is used as in [[Cardiopulmonary resuscitation|CPR]]. However, during the pulse check of '''C''', attempts should also be made to control bleeding and to assess perfusion, usually by checking [[capillary refill]]. Additionally a persons mental status should be assessed ('''D'''isability) or either an [[AVPU]] scale or via a formal [[Glasgow Coma Scale]]. In all but the most minor cases, the patient should be '''E'''xposed by removal of clothing and a secondary survey performed, examining the patient from head to toe for other injuries. The survey should not delay treatment and transport, especially if a non-correctable problem is identified.


=== Minor bleeding ===
=== Minor bleeding ===

Revision as of 04:08, 17 June 2011

WikiDoc Resources for Bleeding

Articles

Most recent articles on Bleeding

Most cited articles on Bleeding

Review articles on Bleeding

Articles on Bleeding in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bleeding

Images of Bleeding

Photos of Bleeding

Podcasts & MP3s on Bleeding

Videos on Bleeding

Evidence Based Medicine

Cochrane Collaboration on Bleeding

Bandolier on Bleeding

TRIP on Bleeding

Clinical Trials

Ongoing Trials on Bleeding at Clinical Trials.gov

Trial results on Bleeding

Clinical Trials on Bleeding at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bleeding

NICE Guidance on Bleeding

NHS PRODIGY Guidance

FDA on Bleeding

CDC on Bleeding

Books

Books on Bleeding

News

Bleeding in the news

Be alerted to news on Bleeding

News trends on Bleeding

Commentary

Blogs on Bleeding

Definitions

Definitions of Bleeding

Patient Resources / Community

Patient resources on Bleeding

Discussion groups on Bleeding

Patient Handouts on Bleeding

Directions to Hospitals Treating Bleeding

Risk calculators and risk factors for Bleeding

Healthcare Provider Resources

Symptoms of Bleeding

Causes & Risk Factors for Bleeding

Diagnostic studies for Bleeding

Treatment of Bleeding

Continuing Medical Education (CME)

CME Programs on Bleeding

International

Bleeding en Espanol

Bleeding en Francais

Business

Bleeding in the Marketplace

Patents on Bleeding

Experimental / Informatics

List of terms related to Bleeding

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Causes, prevalence, and risk factors

Types of bleeding

Bleeding definition for the Cardiovascular Trials

Background, TIMI, GUSTO, CURE, ACUITY HORIZONS, CURRENT OASIS, STEEPLE, PLATO, GRACE, ISAR-REACT3, ESSENCE, the Bleeding Academic Research Consortium (BARC) The incidence of bleeding complications varies from 1% to 10% during treatment of acute coronary syndromes (ACS) and PCI (Percutaneous coronary intervention). This is in part due to use of combination of multiple drugs like aspirin, heparin, warfarin, platelet P2Y12 inhibitors, glycoprotein IIb/IIIa inhibitors, direct thrombin inhibitor and also the invasive procedures (percutaneous coronary intervention, Coronary artery bypass graft) during this period. Also, the bleeding complications have been found to be associated with increase in incidence of short and long term adverse outcomes like death, non-fatal MI (myocardial infarction), stroke and stent thrombosis. The exact mechanism underlying this is not clearly defined but may be due to the cessation of evidence based therapies (like antiplatelet, Beta blockers, statin), effect ofblood transfusion, co morbidities and anemia that are seen more in patients with bleeding complications. Therefore, bleeding presents as an important safety endpoint in many of the cardiovascular trials. However, there is a lack of uniformity in the definitions of bleeding that could be used in the cardiovascular trials that in turn make it difficult to conduct and compare the results of different trials. Several bleeding definitions have been used in different clinical trials – TIMI, GUSTO, CURE, ACUITY HORIZONS, CURRENT OASIS, STEEPLE, PLATO, GRACE, ISAR-REACT3, ESSENCE, Amlani. et.al. .To decrease the heterogeneity and to adopt standardized bleeding end-point definitions for patients receiving antithrombotic therapy, the Bleeding Academic Research Consortium (BARC) was convened comprising representatives from different fields of medicine. These standardized definitions will help researchers determine the relative safety of different antithrombotic therapies. These definitions are recommended for both clinical trials and registries[1].

Causes

First aid

Minor bleeding

Minor bleeding is bleeding that falls under a Class I hemorrhage and the bleeding is easily stopped with pressure.

The largest danger in a minor wound is infection. Bleeding can be stopped with direct pressure and elevation, and the wound should be washed well with soap and water. A dressing, typically made of gauze, should be applied. Peroxide or iodine solutions (such as Betadine) can injure the cells that promote healing and may actually impair proper wound healing and delay closure.[2]

Emergency Bleeding Control

Severe bleeding poses a very real risk of death to the casualty if not treated quickly. Therefore, preventing major bleeding should take priority over other conditions, save failure of the heart or lungs. Most protocols advise the use of direct pressure, rest and elevation of the wound above the heart to control bleeding.

The use of a tourniquet is not advised in most cases, as it can lead to unnecessary necrosis or even loss of a limb. Tourniquets should rarely be used as it is usually possible to stop bleeding by the application of manual pressure.

Bleeding from body cavities

The only minor situation is a spontaneous nosebleed, or a nosebleed caused by a slight trauma (such as a child putting his finger in his nose).

Simultaneous externalised bleeding from the ear may indicate brain trauma if there has been a serious head injury. Loss of consciousness, amnesia, or fall from a height increases the likelihood that there has been a severe injury. This type of injury can also be found in motor vehicle accidents associated with death or severe injury to other passengers.

Hemoptysis, or coughing up blood, may be a sign that the person is at risk for serious bleeding. This is especially the case for patients with cancer. Hematemesis is vomiting up blood from the stomach. Often, the source of bleeding is difficult to distinguish and usually requires detailed assessment by an emergency physician.

Internal bleeding

Internal bleeding occurs entirely within the confines of the body and can be caused by a medical condition (such as aortic aneurysm) or by trauma. Symptoms of internal bleeding include pale, clammy skin, an increased heart rate and a stupor or confused state.

The most recognizable form of internal bleeding is the contusion or bruise.

Risk of blood contamination

Because skin is watertight, there is no immediate risk of infection to the aide from contact with blood, provided the exposed area has not been previously wounded or diseased. Before any further activity (especially eating, drinking, touching the eyes, the mouth or the nose), the skin should be thoroughly cleaned in order to avoid cross contamination.

To avoid any risk, the hands can be prevented from contact with a glove (mostly latex or nitrile rubber), or an improvised method such as a plastic bag or a cloth. This is taught as important part of protecting the rescuer in most first aid protocols.

Following contact with blood, some rescuers may choose to go to the emergency department, where post-exposure prophylaxis can be started to prevent blood-borne infection.

As a medical treatment

Before the advent of modern medicine the technique of bloodletting, or phlebotomy, was used for a number of conditions: causing bleeding intentionally to remove a controlled amount of excess or "bad" blood. Phlebotomy is still used as an extremely effective treatment for Haemochromatosis.

References

  1. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J; et al. (2011). "Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium". Circulation. 123 (23): 2736–47. doi:10.1161/CIRCULATIONAHA.110.009449. PMID 21670242.
  2. Waston, JR et al. Adv Skin Wound Care. 2005 Sep;18(7):373-8. PMID: 16160464

See also


Template:SIB

bg:Кръвоизлив bs:Krvarenje ca:Hemorràgia cs:Krvácení de:Blutung eu:Odoljario it:Emorragia he:דימום la:Haemorrhagia lt:Kraujavimas nl:Versterkte bloedingsneiging qu:Yawar apariy sv:Blödning

Template:WH Template:WS